Portfolio Company · Operating Co.

Sangro

Healthcare

backed byAxcel

CurrentHealthcare

Sangro

a portfolio company of

Axcel

Status on record: Current

Investment year: 2026

PE Firm Index

Who owns Sangro?

Sangro is listed as a current portfolio company of Axcel on Axcel's own portfolio page. Axcel has owned Sangro since 2026, per Axcel's portfolio page.

Company Snapshot

Sangro is a Healthcare company. Its owner on record, Axcel, is a mid-market firm founded in 1994. Axcel lists 40 companies in the index, 6 of them in Healthcare.

SectorHealthcare

Parent PE firmAxcel

Ownership statusCurrent

WebsiteNot on record

About the owner

Axcel

Founded: 1994
Strategy: Mid-market, Commercial Excellence, Buy & Build, Digitalisation, Sustainability
Sectors: Technology, Industrials & Business Services, Healthcare
Companies in the index: 40

Axcel is a mid-market private equity firm that invests in companies where it can apply a structured value creation framework.

Read the Axcel profile

Questions about Sangro

Who owns Sangro?

Sangro is listed as a current portfolio company of Axcel on Axcel's own portfolio page. Axcel has owned Sangro since 2026, per Axcel's portfolio page.

What sector is Sangro in?

Sangro is in Healthcare. Classified from the owner's portfolio label.

What else does Axcel own in Healthcare?

Axcel lists 5 other Healthcare companies in the index, including Aidian, European Sperm Bank, Oral Care, Sanviva and Vetopia.

Sources

Axcel
https://axcel.com/companies/

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Sangro and does not provide investment advice.

Other portfolio companies of Axcel

6 of 39 shown

Accru Partners

Business Services & Industrials

Acurum Group

Business Services & Industrials

AGRD Partners

Business Services & Industrials

See the full Axcel portfolio.

Other Healthcare companies held by Axcel

Aidian European Sperm Bank Oral Care Sanviva Vetopia

Other Healthcare portfolio companies

via Wavemaker 360 Health

3P Biopharmaceuticals

via Marlin Equity Partners

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Axcel

Status: Current

Investment year: 2026

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.